First Manhattan CO Rigel Pharmaceuticals Inc Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $3,560 - $8,260	-2,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.05 $3,948 - $5,739	-2,800 Reduced 58.33%	2,000 $3,000
Q1 2020 May 06, 2020	SELL	$1.27 - $3.0 $1,016 - $2,400	-800 Reduced 14.29%	4,800 $7,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $2.43 $4,160 - $6,318	2,600 Added 86.67%	5,600 $11,000
Q1 2019 Apr 12, 2019	BUY	$2.0 - $2.65 $6,000 - $7,950	3,000 New	3,000 $7,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.91B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.